Close this search box.

We are creating some awesome events for you. Kindly bear with us.

Chinese University of Hong Kong Gets Boost for Biomedical Tech R&D

Image Credits: CUHK, Press Release

The Chinese University of Hong Kong (CUHK) has received a donation of HK$ 150 million from a Hong Kong-based charitable organisation. The donation will be supported by funding and in-kind contributions at CUHK to establish a development fund valued at HK$ 300 million in the Faculty of Medicine (CU Medicine) to support research and development in biomedical technology.

Many of the world’s healthcare systems are struggling under the weight of an ageing population. Concurrently, infectious diseases like COVID-19 and the fallout from the pandemic pose imminent threats to global health. To manage these pressing challenges, the strengthening of medical research as well as the acceleration of the translation of scientific discoveries into clinical applications are crucial.

Given this, CU Medicine has launched the Passion for Perfection (P for P) Scheme to accelerate the process of translating laboratory discovery into patient care – often referred to as a “bench to bedside” process, resulting in medical advances and improved human health. The P for P scheme will also strengthen and protect innovations and intellectual property development, and facilitate entrepreneurship at CUHK, leading to the enhancement and improvement of healthcare in Hong Kong.

The Vice-Chancellor and President of CUHK noted that biomedical research and biotechnology development represent the driver of discoveries and best practices to improve quality of life, essential to societal well-being and economic prosperity in Hong Kong, the nation, and the world. He added that the gift will empower CUHK to build on its world-class strengths in innovative biomedicine, a key pillar of the 2021-25 Strategic Plan that aims for “Excellence with Purpose and Responsibility”, to break new grounds in frontier biomedical research and translational developments to transform patient care and public health.

Meanwhile, the Pro-Vice-Chancellor of CUHK stated that through the donation, CU Medicine will launch an innovative “Passion for Perfection” (P for P) scheme, providing funding to support projects that have the potential to develop useful new diagnostic tools or therapeutic approaches.

CU Medicine will also strengthen its existing clinical trial centre to facilitate the clinical evaluation of these new tools and accelerate the translation of basic research outputs into clinical applications, thereby enhancing CUHK’s translational clinical research.

Specifically, two initiatives will be undertaken:

  1. Development of Prototypes of New Diagnostic or Therapeutic Approaches

A new funding scheme will be launched to support research on novel diagnostic tools that will enable patients to seek early medical treatment and significantly improve their chances of recovery. Research on the development of advanced therapeutic products, particularly those based on novel modalities such as cellular, genetic, and biologic agents, will also be supported. A sustainable innovation ecosystem will be in place to promote the establishment of start-ups such that outstanding research outcomes can be translated and commercialised.

  1. Enhancement of Infrastructure to Facilitate Clinical Validation of the New Approaches

Clinical evaluation in relevant patient cohorts is a key step to bring new diagnostic and therapeutic approaches to routine clinical use. To expedite the “bench to bedside” process, a dedicated team will be established in the existing clinical trial centre, responsible for patient recruitment, clinical evaluation and timely reporting of patient progress, and monitoring of safety and emerging ethical issues. The goal is to increase the speed and efficiency of translating research discoveries to advances in patient care.

The Dean of Medicine at CUHK noted that since its establishment 40 years ago, the faculty has been upholding the core value of patient-centeredness and actively improving the diagnosis, treatment and prevention of diseases through medical research. Their ultimate goal is that their discoveries in research can be practically applied in ways that matter to patients. The donation has greatly enhanced the University’s capability in this translational journey, allowing them to develop world-changing medical technologies for the benefit of patients and the well-being of humankind.


Qlik’s vision is a data-literate world, where everyone can use data and analytics to improve decision-making and solve their most challenging problems. A private company, Qlik offers real-time data integration and analytics solutions, powered by Qlik Cloud, to close the gaps between data, insights and action. By transforming data into Active Intelligence, businesses can drive better decisions, improve revenue and profitability, and optimize customer relationships. Qlik serves more than 38,000 active customers in over 100 countries.


CTC Global Singapore, a premier end-to-end IT solutions provider, is a fully owned subsidiary of ITOCHU Techno-Solutions Corporation (CTC) and ITOCHU Corporation.

Since 1972, CTC has established itself as one of the country’s top IT solutions providers. With 50 years of experience, headed by an experienced management team and staffed by over 200 qualified IT professionals, we support organizations with integrated IT solutions expertise in Autonomous IT, Cyber Security, Digital Transformation, Enterprise Cloud Infrastructure, Workplace Modernization and Professional Services.

Well-known for our strengths in system integration and consultation, CTC Global proves to be the preferred IT outsourcing destination for organizations all over Singapore today.


Planview has one mission: to build the future of connected work. Our solutions enable organizations to connect the business from ideas to impact, empowering companies to accelerate the achievement of what matters most. Planview’s full spectrum of Portfolio Management and Work Management solutions creates an organizational focus on the strategic outcomes that matter and empowers teams to deliver their best work, no matter how they work. The comprehensive Planview platform and enterprise success model enables customers to deliver innovative, competitive products, services, and customer experiences. Headquartered in Austin, Texas, with locations around the world, Planview has more than 1,300 employees supporting 4,500 customers and 2.6 million users worldwide. For more information, visit


SIRIM is a premier industrial research and technology organisation in Malaysia, wholly-owned by the Minister​ of Finance Incorporated. With over forty years of experience and expertise, SIRIM is mandated as the machinery for research and technology development, and the national champion of quality. SIRIM has always played a major role in the development of the country’s private sector. By tapping into our expertise and knowledge base, we focus on developing new technologies and improvements in the manufacturing, technology and services sectors. We nurture Small Medium Enterprises (SME) growth with solutions for technology penetration and upgrading, making it an ideal technology partner for SMEs.


HashiCorp provides infrastructure automation software for multi-cloud environments, enabling enterprises to unlock a common cloud operating model to provision, secure, connect, and run any application on any infrastructure. HashiCorp tools allow organizations to deliver applications faster by helping enterprises transition from manual processes and ITIL practices to self-service automation and DevOps practices. 


IBM is a leading global hybrid cloud and AI, and business services provider. We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. Nearly 3,000 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and business services deliver open and flexible options to our clients. All of this is backed by IBM’s legendary commitment to trust, transparency, responsibility, inclusivity and service.